Countermeasures Against Chemical Threats (CounterACT) Research Network Annual Symposium
|
Meeting/ Workshop
|
CDC, FDA, OS
|
NINDS, NEI, NIAID, NIAMS, NICHD, NIEHS, NIGMS
|
This workshop was organized by NINDS as part of the Countermeasures Against Chemical Threats (CounterACT) Research Network, a group formed to conduct basic, translational, and clinical research aimed at the discovery and/or identification of better therapeutic and diagnostic medical countermeasures against chemical threat agents. The 3-day meeting allowed researchers to share information, encouraged collaboration, and enabled NIH staff to evaluate the group’s progress on themes such as nerve agents, seizure detection technology, cyanide, and sulfur mustard.
|
Countermeasures Against Chemical Threats (CounterACT) Research Network Working Group
|
Committee, Work group, Advisory group, or Task Force
|
OS
|
NICHD, NHLBI, NIAID, NIAMS, NIEHS
|
An OB-Pediatric representative is on the program staff of the Countermeasures Against Chemical Threats (CounterACT) section of NINDS. The collaboration''s function is to prioritize/fund/manage studies focusing on the development of medical countermeasures (MCMs) for protection against chemical agents.
|
Country Stakeholder Meeting – Kenya
|
Other
|
CDC
|
NCI, FIC, NIAID
|
Kenya has an estimated population of over 42 million. Cancer ranks third as a cause of death after infectious and cardiovascular diseases. It estimated that over 18,000 Kenyans die of cancer annually. The most common types of cancer in Kenya are cancers of the cervix, breast, esophagus and prostate. The Ministry of Health released a National Cancer Control Strategy (2010-2015) and a National Cervical Cancer Prevention Program Strategic Plan (2012-2015). NCI looks to build upon those efforts in coordination with the many US government and non-governmental partners (NGOs) working in country. US government agencies, including the National Cancer Institute (NCI), the National Institute of Allergy and Infectious Disease (NIAID), the Fogarty International Center (FIC), the Centers for Disease Control (CDC), and the US Agency for International Development (USAID) have a significant presence in Kenya. Between FY2010 and FY2012, there were 121 NIH or CDC awards totaling $160.1M. USAID invested $700 million in Kenya in FY2011. At least 6 NCI-designated cancer centers have activities in Kenya ranging from capacity building for cancer screening and treatment, to studies of cancers associated with chronic infection, including HPV. Notably, Moi University has hosted the Academic Model Providing Access to Healthcare (AMPATH), in partnership with Indiana University (IU), since 2001. The AMPATH-Moi-IU partnership has created the largest clinical research data enterprises in the developing world and includes 18 HIV clinics in western Kenya with 2,000 new patients enrolling per month as of 2012.
|
Creutzfeldt-Jakob Disease Surveillance in Recipients of Human Growth Hormone, National Hormone and Pituitary Program (NHPP)
|
Resource Development
|
CDC, FDA
|
NIDDK
|
From 1963 to 1985, the National Hormone and Pituitary Program (NHPP), funded by the U.S. Department of Health and Human Services (HHS), sent Human Growth Hormone (HGH) made from human pituitary glands to hundreds of doctors across the country. As a part of research studies, doctors used the hormone to treat nearly 7,700 children for failure to grow. In 1985, the HHS learned that three people treated with pituitary HGH died of Creutzfeldt-Jakob Disease (CJD), a rare, incurable brain disease. The HHS immediately stopped distributing the hormone and began a national study to learn more about how pituitary HGH treatment may have caused this problem.
|
DAIDS (NIH/NIAID) and DTBE (CDC/NCHHSTP) Partnership for TB and TB/HIV Research
|
Research Initiative
|
CDC
|
NIAID
|
This research initiative will conduct pyrazinamide (PZA) resistance profiling.
|
DailyMed
|
Resource Development
|
FDA
|
NLM
|
DailyMed provides high quality information about marketed drugs, including FDA labels (package inserts). The Web site provides health information providers and the public with a standard, comprehensive, up-to-date, look-up and download resource of medication content and labeling as found in medication package inserts. NLM provides this DailyMed as a public service, free of advertising.
|
Data Access for Grantees
|
Resource Development
|
CMS
|
NIA
|
NIA developed a Memorandum of Understanding (MOU) to assist grantees with accessing Centers for Medicare & Medicaid Services (CMS) data. It is anticipated that this initiative will create a more user friendly and more cost efficient means for grantees to access CMS data especially the need to access Part D data. Specifically, this MOU gives CMS''s Privacy Board justification to release Part D data to NIA grantees with Data Use Agreements. Researchers pay for data use. This includes activities for remote access data enclave.
|
Data to Action Research Capacity Building Workshops
|
Meeting/ Workshop
|
CDC
|
NCI
|
NCI and CDC co-organized a preconference workshop at the 1st International Conference on Public Health in the 21st Century: The End-Game for Tobacco. The workshop, ‘Data to Action,’ was aimed at building capacity for research and data collection among Low and Middle Income Countries (LMICs). The preconference was attended by 50 participants representing India, State Health Officers, Epidemic Intelligence Service (EIS) participants, and several countries (including Indonesia, Bangladesh, Turkey, Thailand, Ukraine, and Nigeria).
|
Demand Reduction Interagency Working Groups
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, HRSA, OS, SAMHSA
|
NIAAA, NIDA
|
These working groups aim to prevent substance abuse and related negative consequences by implementing a prevention framework to serve as a foundation for collaboration among Federal agencies in the development of joint initiatives that serve States and communities across the Nation.
|
Department of Defense Resuscitation and Transfusion Steering Committee
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
CC, NHLBI
|
Oversees DoD research in resuscitation and transfusion.
|